Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEPHALEXIN vs CERTOLIZUMAB PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEPHALEXIN vs CERTOLIZUMAB PEGOL: Safety Overview

Metric CEPHALEXIN CERTOLIZUMAB PEGOL
Total FAERS Reports 7,901 99,098
Deaths Reported 295 5,361
Death Rate 3.7% 5.4%
Hospitalizations 1,832 17,641
Average Patient Age 54.7 yrs 49.5 yrs
% Female Patients 73.4% 83.1%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer AMELLA PHARMA, LLC UCB, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription